SINO BIOPHARMACEUTICAL revenue breakdown overview

SINO BIOPHARMACEUTICAL revenue for the last year amounted to 28.82 B HKD, the most of which — 28.48 B HKD — came from its highest performing source at the moment, Modernised Chinese Medicines and Chemical Medicines, the year earlier bringing 32.83 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SINO BIOPHARMACEUTICAL 28.95 B HKD, and the year before that — 33.47 B HKD.